Effects of TMEM206 on the malignant behavior of HepG2 human hepatocellular carcinoma cells

Effects of TMEM206 on the malignant behavior of HepG2 human hepatocellular carcinoma cells

Objective: Hepatocellular carcinoma (HCC) is the most common cancer of the digestive system. Recently, transmembrane proteins (TMEMs) have been extensively studied in different types of malignant tumors. However, the influence of TMEM206 in hepatocellular carcinoma is unclear. Methods: The UALCAN da...

Full description

Bibliographic Details
Main Authors:	Ling Song, Dou Feng, Jiajie Tan, Hong Zhang
Format:	Article
Language:	English
Published:	SAGE Publishing 2022-08-01
Series:	European Journal of Inflammation
Online Access:	https://doi.org/10.1177/1721727X221122724

Similar Items

Assessment of anticancer activity of on hepatocellular carcinoma HepG2 cell line
by: Manal A Emam, et al.
Published: (2019-10-01)

Aucubin inhibits the proliferation of human hepatocellular carcinoma cells line HepG2
by: AN Qi, QI Guangzhao, HAN Chao
Published: (2024-03-01)

Antiproliferative and Apoptotic Effects of Cardamonin against Hepatocellular Carcinoma HepG2 Cells
by: Nassrin A. Badroon, et al.
Published: (2020-06-01)

Silencing of the gene suppresses proliferation and invasion of hepatocellular carcinoma HepG2 cells
by: Jian Zhang, et al.
Published: (2019-03-01)

The effects and mechanism of peiminine-induced apoptosis in human hepatocellular carcinoma HepG2 cells.
by: Xu Chao, et al.
Published: (2019-01-01)

Dehydrocostuslactone inhibits proliferation and promotes apoptosis of human hepatocellular carcinoma cell line HepG2
by: MIAO Jia-wei, CHEN Jie, DENG Xue-song, XIONG Shu, LI Guo-li, MA Qiang
Published: (2020-10-01)

Suppression of the Viability and Proliferation of HepG2 Hepatocellular Carcinoma Cell Line by Konjac Glucomannan
by: Sawai, Sakunie, et al.
Published: (2019)

Antioxidant and Pro-oxidant Effects of Aminoguanidine on HepG-2 Hepatocellular Carcinoma Cell Line
by: Amir Najafi, et al.
Published: (2019-05-01)

CA3 Induces Apoptosis of Hepatocellular Carcinoma HepG2 Cells and Related Mechanism
by: ZHANG Shuwen, et al.
Published: (2020-05-01)

Inducible T-cell co-stimulators regulate the proliferation and invasion of human hepatocellular carcinoma HepG2 cells
by: Yaning Wei, et al.
Published: (2018-01-01)

A secretome profile indicative of oleate-induced proliferation of HepG2 hepatocellular carcinoma cells
by: Soyeon Park, et al.
Published: (2018-08-01)

Effects of thymoquinone and thymoquinone-loaded nanostructured lipid carrier on hepatocellular carcinoma cell models, Hep3B and HepG2
by: Haron, Aminah Suhaila
Published: (2017)

Taurine combined with SN50 inhibits the proliferation of human hepatocellular carcinoma cell line HepG2
by: LEI Qiao-li, RAO Qi-bin, LIN Ze-wen
Published: (2020-03-01)

PP4R1 Accelerates Cell Growth and Proliferation in HepG2 Hepatocellular Carcinoma [Retraction]
by: Wu G, et al.
Published: (2023-06-01)

Knockdown of Decoy Receptor 3 Impairs Growth and Invasiveness of Hepatocellular Carcinoma Cell Line of HepG2
by: Xiao-Na Zhou, et al.
Published: (2016-01-01)

Transformation of HepG2 nascent lipoproteins by LCAT: modulation by HepG2 d > 1.235 g/ml fraction.
by: MR McCall, et al.
Published: (1993-01-01)

HepG2 exosomes coated luteolin nanoparticles remodeling hepatic stellate cells and combination with sorafenib for the treatment of hepatocellular carcinoma
by: Shengjie Ye, et al.
Published: (2024-02-01)

Ni/Mn-Complex-Tethered Tetranuclear Polyoxovanadates: Crystal Structure and Inhibitory Activity on Human Hepatocellular Carcinoma (HepG-2)
by: Fumei Shi, et al.
Published: (2023-09-01)

Analysis of genomic copy number variations in human hepatocellular carcinoma cell lines HepG2 and Huh7
by: JI Mengdie, YUAN Zan, BIAN Xiaocui, YANG Yurong, GUO Xin, WANG Qi, CHEN Yang
Published: (2023-06-01)

Genotoxic Effects of Cylindrospermopsin, Microcystin-LR and Their Binary Mixture in Human Hepatocellular Carcinoma (HepG2) Cell Line
by: Leticia Díez-Quijada, et al.
Published: (2020-12-01)

Flavonoids of Rosa rugosa Thunb. inhibit tumor proliferation and metastasis in human hepatocellular carcinoma HepG2 cells
by: Zhiguo Zhang, et al.
Published: (2022-03-01)

Celastrus orbiculatus extracts induce apoptosis in mTOR-overexpressed human hepatocellular carcinoma HepG2 cells
by: Yayun Qian, et al.
Published: (2018-12-01)

Anti-GPC3 antibody-modified sorafenib-loaded nanoparticles significantly inhibited HepG2 hepatocellular carcinoma
by: Xiaolong Tang, et al.
Published: (2018-01-01)

Effect of Genistein and 17-β Estradiol on the Viability and Apoptosis of Human Hepatocellular Carcinoma HepG2 cell line
by: Masumeh Sanaei, et al.
Published: (2017-01-01)

The CpG Island-Binding Protein SAMD1 Contributes to an Unfavorable Gene Signature in HepG2 Hepatocellular Carcinoma Cells
by: Clara Simon, et al.
Published: (2022-04-01)

Farnesiferol C Exerts Antiproliferative Effects on Hepatocellular Carcinoma HepG2 Cells by Instigating ROS-Dependent Apoptotic Pathway
by: Ahmed Alafnan, et al.
Published: (2022-08-01)

Improvement of solubilization and uptake of dietary antioxidants in human hepatocellular liver carcinoma (HepG2) cell line (PDNP4)
by: Jaswir, Irwandi, et al.
Published: (2009)

New Method for Improving solubilization and uptake of lutein and carotenoids in human hepatocellular liver carcinoma (HepG2) cell culture
by: Jaswir, Irwandi, et al.
Published: (2009)

Characterization of In Vitro 3D Cell Model Developed from Human Hepatocellular Carcinoma (HepG2) Cell Line
by: Martina Štampar, et al.
Published: (2020-11-01)

Hepatitis c virus genotype 4 replication in the hepatocellular carcinoma cell line HepG2/C3A
by: Medhat K Shier, et al.
Published: (2016-01-01)

Cytotoxic Activity of Origanum Vulgare L. on Hepatocellular Carcinoma cell Line HepG2 and Evaluation of its Biological Activity
by: Hazem S. Elshafie, et al.
Published: (2017-08-01)

S-phase cell cycle arrest, and apoptotic potential of Echium arabicum phenolic fraction in hepatocellular carcinoma HepG2 cells
by: Nael Abutaha, et al.
Published: (2022-01-01)

Biological synthesis, characterization of three metal-based nanoparticles and their anticancer activities against hepatocellular carcinoma HepG2 cells
by: Madiha Younas, et al.
Published: (2021-10-01)

Behavioral Changes in Stem-Cell Potency by HepG2-Exhausted Medium
by: Francesca Balzano, et al.
Published: (2020-08-01)

Identification of targets of JS-K against HBV-positive human hepatocellular carcinoma HepG2.2.15 cells with iTRAQ proteomics
by: Zhengyun Liu, et al.
Published: (2021-05-01)

Cytotoxic Effect of Girinimbine on HepG2 Cells
by: Mohan, Suvita Syam
Published: (2011)

Regulation of squalene epoxidase in HepG2 cells.
by: Y Hidaka, et al.
Published: (1990-11-01)

Effect of PEG-PDLLA polymeric nanovesicles loaded with doxorubicin and hematoporphyrin monomethyl ether on human hepatocellular carcinoma HepG2 cells in vitro
by: Xiang GH, et al.
Published: (2013-12-01)

Critical Investigation of the Usability of Hepatoma Cell Lines HepG2 and Huh7 as Models for the Metabolic Representation of Resectable Hepatocellular Carcinoma
by: Gerda Schicht, et al.
Published: (2022-08-01)

DNMT1/PKR double knockdowned HepG2 (HepG2-DP) cells have high hepatic function and differentiation ability
by: Rieko Tanaka-yachi, et al.
Published: (2022-12-01)